← Back to All US Stocks

AGTX Stock Analysis - Agentix Corp. AI Rating

AGTX OTC Biological Products, (No Diagnostic Substances) NV CIK: 0001603345
Analysis Date: Mar 19, 2026 | Data as of: 2025-12-31
AI Rating
STRONG SELL
95% Confidence

Investment Thesis

Agentix Corp exhibits critical financial distress with zero revenue, negative stockholders' equity of -3.5M, and minimal cash reserves of only 6.4K against 3.5M in liabilities. The company is burning cash at an unsustainable rate with -124.6K free cash flow and demonstrates no viable business operations or path to profitability.

AGTX Strengths

  • -No strengths identified

AGTX Risks

  • ! Zero revenue indicates complete absence of business operations
  • ! Negative equity of -3.5M represents technical insolvency and existential going concern risk
  • ! Cash position of 6.4K provides virtually no runway for operations or debt service
  • ! Operating losses of -390.9K with negative operating cash flow of -123.3K demonstrates unsustainable burn rate
  • ! Liabilities of 3.5M exceed total assets of 6.4K by 546x, indicating balance sheet collapse
  • ! Long-term debt of 85.0K represents unserviceable obligations relative to asset base
  • ! No insider purchases in 90 days suggests lack of confidence from management

Key Metrics to Watch

AGTX Financial Metrics

Revenue
$0.0
Net Income
$-408.5K
EPS (Diluted)
$0.01
Free Cash Flow
$-124.6K
Total Assets
$6.4K
Cash Position
$6.4K

AGTX Profitability Ratios

Gross Margin N/A
Operating Margin N/A
Net Margin N/A
ROE N/A
ROA -6,387.2%
FCF Margin N/A

AGTX Balance Sheet & Liquidity

Current Ratio
0.00x
Quick Ratio
-0.01x
Debt/Equity
N/A
Debt/Assets
54,790.4%
Interest Coverage
-6.60x
Long-term Debt
$85.0K

AGTX 5-Year Financial Trend

AGTX 5-year financial data: Year 2017: Revenue $43.1K, Net Income N/A, EPS N/A. Year 2018: Revenue $2.3K, Net Income N/A, EPS N/A. Year 2020: Revenue $0, Net Income -$363.9K, EPS N/A. Year 2021: Revenue $1.2K, Net Income $0, EPS N/A. Year 2023: Revenue $1.2K, Net Income -$2.6M, EPS N/A.
Revenue
Net Income
EPS (right axis)

5-Year Trend Summary: Agentix Corp.'s revenue has declined by 97% over the 5-year period, indicating business contraction. The most recent EPS of $-0.01 indicates the company is currently unprofitable.

AGTX Growth Metrics (YoY)

Revenue Growth
N/A
Year-over-year
Net Income Growth
N/A
Year-over-year
EPS Growth
N/A
Earnings per share
FCF Margin
N/A
Free cash flow / Revenue

AGTX Quarterly Performance

Quarterly financial performance data for Agentix Corp. including revenue, net income, and earnings per share.
Quarter Revenue Net Income EPS
Q3 2023 N/A -$164.7K N/A
Q2 2023 N/A -$164.7K N/A
Q3 2021 N/A N/A N/A
Q2 2021 N/A -$216.7K N/A
Q1 2021 N/A -$216.7K N/A
Q3 2020 N/A -$9.6K N/A
Q3 2018 $2.3K -$38.5K N/A
Q2 2018 $2.3K -$48.3K N/A

Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.

AGTX Capital Allocation

Operating Cash Flow
-$123.3K
Cash generated from operations
Capital Expenditures
$1.3K
Investment in assets
Dividends
None
No dividend program

AGTX SEC Filings

Access official SEC EDGAR filings for Agentix Corp. (CIK: 0001603345)

📄 10-K Annual Reports 📋 10-Q Quarterly Reports 📰 8-K Current Reports 📊 Proxy Statements 🔍 All Filings

Related Stock Analysis

TFX
TELEFLEX INC
STRONG SELL
NWL
NEWELL BRANDS INC.
STRONG SELL
Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: Mar 19, 2026 | Data as of: 2025-12-31 | Powered by Claude AI